home
RRP ISA Survey Results


    AAV2

    by National Cancer Institute
    July 5, 2005
    http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_070505/page2

    From article by Kathy Blankenship, with response from Michael Green:

    These articles about the AAV2 virus and HPV and associated cancers are quite interesting. There is a need for more research into this and other HPV treatments. One of the tasks of the International RRP ISA Center is to investigate and support further research into potential treatments for RRP patients.

    Only single cell lines of breast, squamous cell, and prostate cancer were studied. Not so for human papillomavirus (HPV)-related cervical cancer, explains Dr. Craig Meyers, professor of microbiology and immunology at the Penn State College of Medicine and the lead investigator on the study.

    "We did the experiment 30 or 40 times with all different types of [HPV-related] cervical cancer lines: preneoplastic, ...invasive carcinoma, HPV16, HPV18, HPV31," he says. "Every single time, they died at 6 days, like clockwork." The 6-day time frame for cell death held true for all four cell types studied.

    Study: Harmless virus kills some cancers
    EurekAlert - Washington,DC,USA

    http://www.eurekalert.org/pub_releases/2005-06/ps-shv062105.php

    ... reason why remains unclear, population-based studies have shown that people who carry AAV2 tend not to develop human papillomavirus- (HPV-) associated cervical ...